Escitalopram for recurrent isolated sleep paralysis.
Journal of Sleep Research December 1, 2020 Jonathan P Hintze, Dominic Gault
Recurrent isolated sleep paralysis, which can be very disturbing and provoke anxiety, is usually treated with cognitive and behavioural therapies, but some patients may benefit from medication. With limited evidence available, there are no standardized pharmacologic recommendations. This report describes the first two cases where escitalopram, a selective serotonin reuptake inhibitor, successfully treated recurrent isolated sleep paralysis. Escitalopram generally improves subjective sleep quality, making it an appealing treatment option.